Anavex Life Sciences Announces Grant Of U.S. Patent Covering Blarcamesine For Treatment Of Insomnia Or Anxiety
Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental